In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry
暂无分享,去创建一个
Philip S Low | Ji-Xin Cheng | P. Low | L. Hartmann | Ji‐Xin Cheng | Haifeng Wang | Wei He | Haifeng Wang | Lynn C Hartmann | Wei He
[1] P. Low,et al. Evaluation of Folate Conjugate Uptake and Transport by the Choroid Plexus of Mice , 2003, Pharmaceutical Research.
[2] B R Masters,et al. Two-photon excitation fluorescence microscopy. , 2000, Annual review of biomedical engineering.
[3] Beop-Min Kim,et al. Simple high-speed confocal line-scanning microscope. , 2005, Optics express.
[4] P. Low,et al. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] Charles P. Lin,et al. Real-time Detection of Circulating Apoptotic Cells by in Vivo Flow Cytometry , 2005, Molecular imaging.
[6] Tayyaba Hasan,et al. Flow Cytometry : A New Method for Enumerating Circulating Cancer Cells , 2004 .
[7] P. Kenemans,et al. Comparative Immunohistochemical Study of Four Monoclonal Antibodies Directed Against Ovarian Carcinoma‐Associated Antigens , 1991, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[8] S. Achilefu,et al. Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform. , 2001, Journal of biomedical optics.
[9] Philip S Low,et al. Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopy. , 2004, American journal of physiology. Cell physiology.
[10] Charles P. Lin,et al. In vivo flow cytometer for real-time detection and quantification of circulating cells. , 2004, Optics letters.
[11] P. Saigo,et al. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. , 1993, The American journal of pathology.
[12] T. Gómez-Cía,et al. Flow changes in forearm arteries after elevating the radial forearm flap: prospective study using color duplex imaging. , 1999, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[13] Jonathan W. Uhr,et al. Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.
[14] P. Low,et al. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. , 2005, Analytical biochemistry.
[15] P. Low,et al. Ligand Binding and Kinetics of Folate Receptor Recycling in Vivo: Impact on Receptor-Mediated Drug Delivery , 2004, Molecular Pharmacology.
[16] Jing Yong Ye,et al. Multiphoton in vivo flow cytometry , 2005, (CLEO). Conference on Lasers and Electro-Optics, 2005..
[17] J. Ross,et al. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications , 1994, Cancer.
[18] I. Rosenberg,et al. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. , 2007, The American journal of clinical nutrition.
[19] J. Reddy,et al. Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] David A. Benaron,et al. The Future of Cancer Imaging , 2004, Cancer and Metastasis Reviews.
[21] P. Sperryn,et al. Blood. , 1989, British journal of sports medicine.
[22] J. Reddy,et al. Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical. , 2002, Bioconjugate chemistry.
[23] B. Molnár,et al. Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[24] Thomas Rau,et al. Circulating Tumor Cells in Breast Cancer: Correlation to Bone Marrow Micrometastases, Heterogeneous Response to Systemic Therapy and Low Proliferative Activity , 2005, Clinical Cancer Research.
[25] Alison Stopeck,et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.
[26] W. Webb,et al. Nonlinear magic: multiphoton microscopy in the biosciences , 2003, Nature Biotechnology.
[27] P. Low,et al. T-cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] L R Coney,et al. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. , 1992, Cancer research.
[29] Alison Stopeck,et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] P. Low,et al. Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors , 2002, Cancer Immunology, Immunotherapy.
[31] M. Pomper,et al. Radiolabeled Small-Molecule Ligands for Prostate-Specific Membrane Antigen: In vivo Imaging in Experimental Models of Prostate Cancer , 2005, Clinical Cancer Research.
[32] Z. Hall. Cancer , 1906, The Hospital.
[33] V. Zurawski,et al. Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. , 1992, Cancer research.
[34] J. Scott,et al. Increased adhesion of erythrocytes to components of the extracellular matrix: isolation and characterization of a red blood cell lipid that binds thrombospondin and laminin. , 1996, Blood.
[35] M. Benninger,et al. Micrometastatic tumor detection in patients with head and neck cancer: a preliminary report. , 2002, Archives of otolaryngology--head & neck surgery.
[36] P. Low,et al. Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[37] P. Wilson,et al. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. , 1999, The New England journal of medicine.
[38] R. Wendt,et al. Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.